- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Patent holdings for IPC class C07K 16/30
Total number of patents in this class: 11893
10-year publication summary
|
760
|
916
|
961
|
944
|
967
|
887
|
900
|
853
|
909
|
728
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1157 |
412 |
| Genentech, Inc. | 4008 |
201 |
| Regeneron Pharmaceuticals, Inc. | 4407 |
159 |
| The Regents of the University of California | 20230 |
154 |
| Hoffmann-La Roche Inc. | 3516 |
151 |
| F. Hoffmann-La Roche AG | 7932 |
147 |
| Memorial Sloan-Kettering Cancer Center | 1974 |
135 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2895 |
130 |
| The Trustees of the University of Pennsylvania | 4376 |
119 |
| Amgen Inc. | 4158 |
118 |
| Chugai Seiyaku Kabushiki Kaisha | 1375 |
112 |
| Janssen Biotech, Inc. | 1575 |
105 |
| Amgen Research (Munich) GmbH | 261 |
100 |
| Novartis AG | 10656 |
91 |
| Immunomedics, Inc. | 260 |
90 |
| SeaGen Inc | 594 |
88 |
| The Board of Trustees of the Leland Stanford Junior University | 6509 |
87 |
| Board of Regents, The University of Texas System | 5917 |
87 |
| Dana-Farber Cancer Institute, Inc. | 2615 |
85 |
| Daiichi Sankyo Company, Limited | 1878 |
81 |
| Other owners | 9241 |